Stay updated on Cabotegravir vs TDF/FTC in Women Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.

Latest updates to the Cabotegravir vs TDF/FTC in Women Clinical Trial page
- Check6 days agoChange DetectedThe page now shows a revision tag of v3.6.5, replacing the previous v3.6.4, indicating a small update to the page's build. This update does not change study details, eligibility criteria, or the information presented to users.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision number was updated from v3.6.3 to v3.6.4, signaling a small deployment update. No observable changes to the study details or user interactions are expected.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page shows a new revision tag: v3.6.3 replacing the previous v3.6.2, signaling a minor update to the page build. This update does not modify the study content or reported results.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, representing a minor version update. This change does not modify any study content, eligibility criteria, or user-facing information.SummaryDifference0.0%

- Check63 days agoChange DetectedThe recruitment status was updated to No longer looking for participants, new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was standardized with a revision note updated to v3.6.0.SummaryDifference0.3%

- Check70 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a minor maintenance update to the page.SummaryDifference0.0%

Stay in the know with updates to Cabotegravir vs TDF/FTC in Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.